Skip to main content
OpenTrials
Recruiting

NCT Number: NCT05235867

Secretin in Refeeding

Patients with restrictive-type anorexia nervosa who are admitted to the hospital for feeding often urinate excessive amounts. Others have changes in the way that they handle acid and base. These issues prolong hospitalizations. Current data suggest that one hormone--named secretin--may control both urine output and how the body handles acid and base. This study will evaluate whether secretin levels are different in anorexic patients who urinate an excessive amount compared to those who urinate normal amounts. For this study, patients will have one extra blood draw before and after one meal during their hospitalization. The blood draw before the meal coincides with a standard of care blood draw. Also after the meal, subjects will be asked to provide one extra urine sample. Information from subject's medical records will also be used.

Recruiting

Interested in participating?

Request Info

Key information

Age range

13 year–24 year

Sex eligibility

All sexes

Study type

Observational

Primary location

University of California, Los Angeles (UCLA)

Los Angeles, California, 90095, United States

Location status: Recruiting

Location contact

Finnegan Mercer

CONTACT

[email protected]

310-206-7631

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Group 1:
  • male and female patients
  • age 13-24 years
  • diagnosis of restrictive-type anorexia nervosa
  • hospitalization for nutritional support
  • >4 cc/kg/day of urine output (a.k.a. "fluid dumpers"; n=5)
  • Group 2:
  • male and female patients
  • age 13-24 years
  • diagnosis of restrictive-type anorexia nervosa
  • hospitalization for nutritional support
  • <2 cc/kg/d of urine output (a.k.a. "non-dumpers"; n=5)

Exclusion criteria

  • 5150 hold
  • Anti-depressant, anti-psychotic, or anticonvulsant medications
  • Previous hospitalization within the past 6 months
  • Underlying metabolic disorder not related to anorexia nervosa (including chronic kidney disease, renal tubular disorders, and underlying endocrine disorders)
  • Pregnancy
  • NG or G-tube feeds after day 2 of hospitalization
  • > 10% of nutritional needs from supplemental feeds

Treatment and study plan

Primary outcomes

  1. Change in secretin

    Time frame: 1 hour

    Change in secretin value from pre- to post- meal

Secondary outcomes

  1. Change in serum bicarbonate

    Time frame: 1 hour

    Change in bicarbonate value from pre- to post- meal

Study contacts

Contact information is provided by the study sponsor or research team.

Misciel Macaraig

CONTACT

[email protected]

310-825-0922

Sponsors and collaborators

Lead sponsor

University of California, Los Angeles

Other

Registry information

Official study title

Secretin Levels in Refeeding-induced Polyuria (Cross Section)

Important dates

Study start
2022
Primary completion
2027
Study completion
2027
First posted
Feb 11, 2022
Registry last updated
Feb 12, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.